Skip to content

Evaluation of an Ayurvedic Medicine (Musali Khadiradi Kashaya Ghanavati) for the Management of Excessive White Vaginal Discharge in Women

A CLINICAL EVALUATION OF MUSALI KHADIRADI KASHAYA GHANAVATI IN THE MANAGEMENT OF SHWETAPRADARA W.S.R. TO LEUCORRHOEA: A SINGLE GROUP STUDY - NIL

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/06/112999
Enrollment
30
Registered
2026-06-18
Start date
Unknown
Completion date
Unknown
Last updated
2026-06-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N898- Other specified noninflammatory disorders of vagina

Interventions

None listed

Sponsors

Department of Prasutitantra Evam Stree Roga Mahaveer College of Ayurvedic Science
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1 Women aged 21 45 years 2 Patient having symptoms of Shwetapradara 3 Patient having problem of abnormal vaginal discharge with foul odor 4 Patient having symptoms associated with pelvic pain and dysuria 5 Patients are willing for consent and follow-up. 6 Control Blood sugar level

Exclusion criteria

Exclusion criteria: 1 Pregnant/lactating Women 2 Malignancy of Cervix and Uterus 3 Patient having psychological disorder 4 Case undergoing some serious illness-Uncontrolled Diabetes mellitus, heart diseases 5 Patient having cervical or uterine polyp 6 Patient having fibroid, bulky, uterus, PCOS 7 Patient suffering from HIV, STD`S HBsAG 8 Women using OC pills/IUCD 9 Acute urinary tract infection

Design outcomes

Primary

MeasureTime frame
To evaluate the effect of Musali Khadiradi Kashaya Ghanavati on vaginal discharge and its associated symptomsTimepoint: 3 Months

Secondary

MeasureTime frame
1 To prepare and standardize the Musali Khadiradi Kashaya Ghanavati through pharmaceutical procedures 2 To assess the advantages of the Ghanavati form in terms of improved palatability, increased shelf life, and standardization of dosageTimepoint: 3 Months

Countries

India

Contacts

Public ContactDr Hrushikesh Raghuraj Metkari

Mahaveer College of Ayurvedic Science Sundra Rajnandgaon Chhattisgarh 491441

drhrushikeshmetkari@gmail.com8149032828

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Jun 29, 2026